Search

everythinglearnresearchcommunity

for

Search:↓

LPA3 is crucial for embryo implantation and links LPA to prostaglandin signaling.

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

The VEGF +405G allele may increase the risk of PCOS in South Indian women.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

Suppressing certain hormones might help prevent prostate cancer.

The conclusion is that androgenetic alopecia and senescent alopecia have unique gene changes, suggesting different causes and potential treatments for these hair loss types.

NcoA4 may have roles beyond helping control gene activity, possibly affecting cell behavior and stability.

Insulin resistance is linked to high male hormone levels in women, often seen in those with PCOS.

Treatment during development affects hormone balance and sexual behavior in male rats.

Cholesterol balance is important for hair health, and problems with it can lead to hair loss conditions.

Using anabolic androgenic steroids can cause serious, lasting health problems in many parts of the body.

Age, smoking, and lower BMI increase facial wrinkles; men wrinkle more than women, except in old age; pale skin and certain hormonal factors can protect against wrinkles.

Most pregnant women experience skin changes like darkening and itching, while serious skin conditions are rare but need early treatment.

Different anti-androgen medications can help treat excessive hair growth, but the right choice depends on accurate diagnosis.

Cyclodextrins improve how steroid drugs work and are used in marketed medications and environmental applications.

Sex hormones affect hair and feather growth and may help manage alopecia and hormone-dependent cancers.

Alopecia Areata is an autoimmune disease affecting hair follicles, influenced by genetic and environmental factors, with rodent models being essential for research.

Benign Prostatic Hyperplasia may be caused by changes in how the body processes male hormones.

Most hirsutism cases are due to PCOS, and treatment focuses on lowering testosterone and blocking its effects.

Treatments for common hair loss include minoxidil, finasteride, and hair transplantation.

Finasteride reduces dihydrotestosterone, increases testosterone, and may treat hirsutism in women.

Women with hyperandrogenic amenorrhea have similar bone density to healthy women but lower than androgenized women without amenorrhea, and high DHEAS levels might affect bone density.

Lack or blocking of SRD5a, a key component in hormone creation, can lead to conditions like pseudohermaphrodism and affect hair growth, bone mass, muscle strength, and reproductive health. More research is needed on its regulation from fertilization to adulthood.

Progesterone byproduct 5αP stimulates mammary tumor growth, but finasteride can suppress it.

Testosterone implants in women require pharmacological dosing to be effective and are generally safe and well-tolerated.

Dutasteride does not impair mental function in elderly men with enlarged prostate.

Low vitamin D receptor levels found in hair loss patients; topical vitamin D treatment suggested.

Poor maternal nutrition can lead to fewer wool follicles in Chinese Merino sheep.

Finasteride and dutasteride reduce neurosteroid production, possibly helping treat glioblastoma.